NCT00413608View on ClinicalTrials.gov

Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Healthy
Interventions
DRUG

Clopidogrel

Clopidogrel

Trial Locations (1)

75015

Hôpital Européen Georges Pompidou, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00413608 - Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects | Biotech Hunter | Biotech Hunter